Targeting EZH2 increases the vulnerability of triple-negative breast cancer. Targeting EZH2 increases the vulnerability of triple-negative breast cancer

We hypothesize that knockdown or inhibition of the EZH2 results in decreased proliferation and tumorigenic potential of TNBC breast cancer cells Overall design: Examination of gene expression in three TNBC breast cancer cell lines following knockdown of EZH2 or chemical inhibition of EZH2 activity